Prognostic and predictive value of FCER1G in glioma outcomes and response to immunotherapy

被引:0
作者
Houshi Xu
Qingwei Zhu
Lan Tang
Junkun Jiang
Huiwen Yuan
Anke Zhang
Meiqing Lou
机构
[1] Shanghai Jiao Tong University School of Medicine,Department of Neurosurgery, Shanghai General Hospital
[2] Zhejiang University,Department of Neurosurgery, Second Affiliated Hospital, School of Medicine
[3] Tongji University,undefined
来源
Cancer Cell International | / 21卷
关键词
Gliomas; Immunotherapy; T cell; FCER1G; biomarker;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Expression status and prognostic value of cancer/testis antigen OY-TES-1 in glioma
    Shi, Lei
    Zhang, Qing-Mei
    Wei, Zong-Dang
    Luo, Bin
    Fu, Jun
    Peng, Ya
    Hu, Qi-Ping
    Chen, Fang
    Ge, Ying-Ying
    Xiao, Shao-Wen
    Xie, Xiao-Xun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (02): : 1598 - 1607
  • [32] Prognostic value of WT1 protein expression level and MIB-1 staining index as predictor of response to WT1 immunotherapy in glioblastoma patients
    Yasuyoshi Chiba
    Naoya Hashimoto
    Akihiro Tsuboi
    Carter Rabo
    Yoshihiro Oka
    Manabu Kinoshita
    Naoki Kagawa
    Yusuke Oji
    Haruo Sugiyama
    Toshiki Yoshimine
    Brain Tumor Pathology, 2010, 27 : 29 - 34
  • [33] Prognostic and Predictive Value of PBRM1 in Clear Cell Renal Cell Carcinoma
    Carril-Ajuria, Lucia
    Santos, Maria
    Maria Roldan-Romero, Juan
    Rodriguez-Antona, Cristina
    de Velasco, Guillermo
    CANCERS, 2020, 12 (01)
  • [34] Comprehensive analyses of PDHA1 that serves as a predictive biomarker for immunotherapy response in cancer
    Deng, Langmei
    Jiang, Anqi
    Zeng, Hanqing
    Peng, Xiaoji
    Song, Liying
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [35] Predictive value of thrombospondin-1 for outcomes in patients with acute ischemic stroke
    Gao, Jian-Bo
    Tang, Wei-Dong
    Wang, Hong-Xiang
    Xu, Yan
    CLINICA CHIMICA ACTA, 2015, 450 : 176 - 180
  • [36] Prognostic value of WT1 protein expression level and MIB-1 staining index as predictor of response to WT1 immunotherapy in glioblastoma patients
    Chiba, Yasuyoshi
    Hashimoto, Naoya
    Tsuboi, Akihiro
    Rabo, Carter
    Oka, Yoshihiro
    Kinoshita, Manabu
    Kagawa, Naoki
    Oji, Yusuke
    Sugiyama, Haruo
    Yoshimine, Toshiki
    BRAIN TUMOR PATHOLOGY, 2010, 27 (01) : 29 - 34
  • [37] Use of 11C-methionine PET parametric response map for monitoring WT1 immunotherapy response in recurrent malignant glioma Clinical article
    Chiba, Yasuyoshi
    Kinoshita, Manabu
    Okita, Yoshiko
    Tsuboi, Akihito
    Isohashi, Kayako
    Kagawa, Naoki
    Fujimoto, Yasunori
    Oji, Yusuke
    Oka, Yoshihiro
    Shimosegawa, Eku
    Morita, Satoshi
    Hatazawa, Jun
    Sugiyama, Haruo
    Hashimoto, Naoya
    Yoshimine, Toshiki
    JOURNAL OF NEUROSURGERY, 2012, 116 (04) : 835 - 842
  • [38] COL12A1 as a prognostic biomarker links immunotherapy response in breast cancer
    Yan, Yuanliang
    Liang, Qiuju
    Liu, Yuanhong
    Zhou, Shangjun
    Xu, Zhijie
    ENDOCRINE-RELATED CANCER, 2023, 30 (05)
  • [39] Comprehensive pan-cancer analysis reveals NUSAP1 is a novel predictive biomarker for prognosis and immunotherapy response
    Zheng, Hong
    Wang, Minghao
    Zhang, Shiyu
    Hu, Dongxue
    Yang, Qiaoyun
    Chen, Ming
    Zhang, Xia
    Zhang, Yi
    Dai, Jigang
    Liou, Yih-Cherng
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2023, 19 (14): : 4689 - 4708
  • [40] LNX1-AS2 as a Key Prognostic and Immunotherapy Response Biomarker for Lung Adenocarcinoma
    Wang, Xiuxiu
    Yan, Guanzhong
    Zhang, Xiaoying
    Li, Dongbing
    Li, Guangyi
    CURRENT MEDICINAL CHEMISTRY, 2024,